Pharmaceutically Actives>API’s & Intermediates

(±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research.

(±)-LY367385 is a selective mGlu1a antagonist.

(±)-LY 395756 is a mixed mGlu2 agonist/mGlu3 antagonist.